D454-0195 Screening compound: N~2~-{5-[3,4-dihydropyrazino[1,2-a][1,3]benzimidazol-2(1H)-yl]-2-methylphenyl}-2-furamide

D454-0195 Screening compound: N~2~-{5-[3,4-dihydropyrazino[1,2-a][1,3]benzimidazol-2(1H)-yl]-2-methylphenyl}-2-furamide
D454-0195 Screening compound: N~2~-{5-[3,4-dihydropyrazino[1,2-a][1,3]benzimidazol-2(1H)-yl]-2-methylphenyl}-2-furamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D454-0195
N~2~-{5-[3,4-dihydropyrazino[1,2-a][1,3]benzimidazol-2(1H)-yl]-2-methylphenyl}-2-furamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D454-0195

Molecular Formula

C22H20N4O2 (C22 H20 N4 O2)

Compound Name

N~2~-{5-[3,4-dihydropyrazino[1,2-a][1,3]benzimidazol-2(1H)-yl]-2-methylphenyl}-2-furamide

IUPAC name

N-(2-methyl-5-{1811-triazatricyclo[7.4.0.0^{27}]trideca-2468-tetraen-11-yl}phenyl)furan-2-carboxamide

SMILES

Cc(ccc(N1Cc2nc(cccc3)c3n2CC1)c1)c1NC(c1ccco1)=O

InChI

InChI=1S/C22H20N4O2/c1-15-8-9-16(13-18(15)24-22(27)20-7-4-12-28-20)25-10-11-26-19-6-3-2-5-17(19)23-21(26)14-25/h2-9,12-13H,10-11,14H2,1H3,(H,24,27)

InChI Key

ZXMMCBXRRTVBLE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14829555

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

372.43

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.610

Distribution Coefficient, logD

3.610

Water Solubility, LogSw

-3.62

Polar Surface Area

45.605

Acid Dissociation Constant (pKa)

11.19

Base Dissociation Constant (pKb)

3.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

D454-0195 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Antiviral Library (67538 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D454-0195 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D454-0195?
Check Price and Availability of D454-0195, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D454-0195 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D454-0195
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D454-0195
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D454-0195 available by request